deoxyepinephrine has been researched along with Fatty Liver, Nonalcoholic in 1 studies
Deoxyepinephrine: Sympathomimetic, vasoconstrictor agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Decara, JM | 1 |
| Pavón, FJ | 1 |
| Suárez, J | 1 |
| Romero-Cuevas, M | 1 |
| Baixeras, E | 1 |
| Vázquez, M | 1 |
| Rivera, P | 1 |
| Gavito, AL | 1 |
| Almeida, B | 1 |
| Joglar, J | 1 |
| de la Torre, R | 1 |
| Rodríguez de Fonseca, F | 1 |
| Serrano, A | 1 |
1 other study available for deoxyepinephrine and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Treatment with a novel oleic-acid-dihydroxyamphetamine conjugation ameliorates non-alcoholic fatty liver disease in obese Zucker rats.
Topics: Adiposity; Animals; Body Weight; Deoxyepinephrine; Ether-A-Go-Go Potassium Channels; Feeding Behavio | 2015 |